Suvoda and Celgene to present how advanced IRT functionality solves unique challenges in oncology.
Oncology trials have unique requirements that can present challenges for interactive response technology (IRT) systems. An advanced IRT system that has the flexibility to handle unique aspects of oncology studies can simplify the complexity of managing such studies and dramatically reduce the burden on the sponsor. To implement a flexible IRT system successfully, it’s important to look at new ways to approach system functionality that can account for the “known” unknowns that make oncology trials especially difficult to design and maintain.
This webinar will go through Celgene’s clinical protocol in case study format and how Suvoda’s IRT system helped simplify complexities while addressing specific business needs. The webinar will cover aspects of the clinical protocol that are traditionally obstacles for IRT systems and solutions for those obstacles. The webinar will then evaluate the success of the flexible IRT system design one year after deployment.
Register for this webinar to learn how Suvoda helped Celgene design a system that is flexible enough to handle:
- Subject-specific dynamic visit schedules to manage an unknown number of repeating cycles
- Unknown cohorts and cohort doses
- Unknown number of unscheduled, dose titrating visits
- Multiple phase management with different disease/tumor type management per phase